Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study

PloS One
Katsuhiro YoshikawaTomoharu Sugie

Abstract

Adipophilin is a lipid droplet-associated protein whose expression can act as a prognostic marker for specific cancers. Using immunohistochemical staining and tissue microarrays, we assayed the expression of adipophilin in 61 patients with triple-negative breast cancer (TNBC) who underwent surgery from January 2006-December 2018. Relapse-free survival (RFS) and its risk factors were analyzed based on adipophilin expression. Fourteen (23.0%) patients expressed adipophilin. As compared to the adipophilin-negative TNBC patients, adipophilin-positive patients exhibited poor RFS (p = 0.032). Among the TNBC patients with a high Ki-67 labeling index, patients negative for adipophilin exhibited better RFS than patients positive for adipophilin (p = 0.032). Moreover, among patients who did not undergo adjuvant chemotherapy, patients negative for adipophilin expression exhibited better RFS than adipophilin-positive patients (p = 0.080). Multivariate analysis showed that adipophilin expression correlated with a high rate of relapse (hazard ratio, 4.89; 95% confidence interval, 1.04-23.0; p = 0.044). Taken together, these results indicate that adipophilin is a novel marker for the poor prognosis of patients with TNBC.

References

Oct 22, 2002·FEBS Letters·Sirkku T SaarikoskiOliver Hankinson
Dec 6, 2006·Cancer·Emad A RakhaIan O Ellis
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masahiro YaoYoshinobu Kubota
Mar 3, 2007·The Lancet Oncology·Susan CleatorR Charles Coombes
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Apr 21, 2009·Biochimica Et Biophysica Acta·Perry E BickelMichael A Welte
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Aug 13, 2009·The Breast Journal·Henry G KaplanMary Atwood
Jun 22, 2010·Cancer·Masakazu ToiUNKNOWN Japan Breast Cancer Research Group-Translational Research Group
Aug 11, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Junichi MatsubaraTesshi Yamada
Nov 10, 2013·Disease Models & Mechanisms·Franziska BaenkeAlmut Schulze
Sep 3, 2016·International Journal of Molecular Sciences·Shiro Koizume, Yohei Miyagi
Nov 26, 2016·Journal of Cutaneous Pathology·Masakazu FujimotoShin-Ichi Murata
Mar 19, 2019·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Yuki HashimotoSohei Satoi

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
biopsy

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

© 2021 Meta ULC. All rights reserved